Predicting Patients’ Response to Immunotherapy from Tumor Histopathology and Blood: Computational Science in Immuno-oncology

July 08, 2025 12:00 p.m. - 1:00 p.m. ET
Virtual

To register to attend, you must log in to your SITC Cancer Immunotherapy CONNECT account. Don’t have an account? Create a free one.

Join Drs. Eytan Ruppin (presenter) and Timothy Shaw (moderator) as they present on four approaches for predicting how patients respond to checkpoint immunotherapy.

  • Approach #1: Predicting patient response to the tumor bulk transcriptome
  • Approach #2: Predicting response directly from the blood via simple routine lab tests and the tumor mutational burden
  • Approach #3: Predicting patient immunotherapy response from the tumor histopathological images
  • Approach #4: Building predictors of the tumor microenvironment and developing spatially grounded biomarkers of treatment response

This webinar is part of the 2025 SITC-NCI Computational Immuno-oncology Webinar Series, which is focusing on methods and clinical utility for biomarker development in immune-oncology. This is the fifth of ten free webinars set to help individual research labs overcome the computational challenges of analyzing and integrating different assay data throughout the spectrum of immuno-oncology for biomarker development. The annual series aims to educate early-career scientists, increase participants’ awareness of and engagement in NCI-supported Immunotherapy Networks, and fulfill the goal of accelerating progress in cancer research.

Eytan Ruppin, M.D., Ph.D.

Dr. Ruppin is the chief and senior investigator of NCI’s Cancer Data Science Laboratory.

Timothy Shaw, Ph.D.

Dr. Timothy Shaw is an assistant member in the Department of Biostatistics and Bioinformatics at the Moffitt Cancer Center.

Vote below about this page’s helpfulness.